Home
COR
COR News

Latest Cencora Inc. (COR) News on November 11, 2025

MT Newswires

a day ago

TD Cowen Adjusts Price Target on Cencora to $400 From $350

MT Newswires

4 days ago

UBS Adjusts Price Target on Cencora to $415 From $380, Maintains Buy Rating

Why Cencora (COR) is a Top Momentum Stock for the Long-Term

Zacks

4 days ago

Why Cencora (COR) is a Top Momentum Stock for the Long-Term

Cencora makes $1 billion investment in pharma supply chains

FreightWaves

5 days ago

Cencora makes $1 billion investment in pharma supply chains

MT Newswires

5 days ago

Morgan Stanley Adjusts Price Target on Cencora to $361 From $330, Maintains Equalweight Rating

MT Newswires

5 days ago

Evercore ISI Adjusts Price Target on Cencora to $400 From $340, Maintains Outperform Rating

MT Newswires

5 days ago

Mizuho Adjusts Price Target on Cencora to $380 From $340, Maintains Outperform Rating

MT Newswires

5 days ago

Citigroup Adjusts Price Target on Cencora to $405 From $355, Maintains Buy Rating

MT Newswires

5 days ago

Baird Adjusts Price Target on Cencora to $395 From $355, Maintains Outperform Rating

Cencora (COR) Q4 Earnings and Revenues Surpass Estimates

Zacks

6 days ago

Cencora (COR) Q4 Earnings and Revenues Surpass Estimates

Drug Distributor Cencora to Invest $1 Billion in U.S. Supply Chain

The Wall Street Journal

6 days ago

Drug Distributor Cencora to Invest $1 Billion in U.S. Supply Chain

Business Wire

6 days ago

Cencora Announces $1 Billion Investment to Strengthen Its U.S. Distribution Network

MT Newswires

6 days ago

Cencora Fiscal Q4 Adjusted Earnings, Revenue Rise; Guides for Fiscal 2026 Growth

Cencora’s (NYSE:COR) Q3 Sales Top Estimates

StockStory

6 days ago

Cencora’s (NYSE:COR) Q3 Sales Top Estimates

Associated Press Finance

6 days ago

Cencora: Fiscal Q4 Earnings Snapshot

Business Wire

6 days ago

Cencora Reports Fiscal 2025 Fourth Quarter and Fiscal Year End Results

Agilon Health (AGL) Reports Q3 Loss, Tops Revenue Estimates

Zacks

7 days ago

Agilon Health (AGL) Reports Q3 Loss, Tops Revenue Estimates

Will Strong Segmental Performance Drive MCK's Top Line in Q2?

Zacks

7 days ago

Will Strong Segmental Performance Drive MCK's Top Line in Q2?

Earnings To Watch: Cencora (COR) Reports Q3 Results Tomorrow

StockStory

7 days ago

Earnings To Watch: Cencora (COR) Reports Q3 Results Tomorrow

Prescription for Beats: 3 Healthcare Stocks Set to Outperform in Q3

Zacks

11 days ago

Prescription for Beats: 3 Healthcare Stocks Set to Outperform in Q3

Countdown to Cencora (COR) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS

Zacks

11 days ago

Countdown to Cencora (COR) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS

Stocks making big moves this week: Cencora, Custom Truck One Source, Kirby, Mister Car Wash, and Cardinal Health

StockStory

11 days ago

Stocks making big moves this week: Cencora, Custom Truck One Source, Kirby, Mister Car Wash, and Cardinal Health

Cencora (COR) Stock Is Up, What You Need To Know

StockStory

12 days ago

Cencora (COR) Stock Is Up, What You Need To Know

Morningstar Research

12 days ago

Analyst Report: Cardinal Health, Inc.

Viatris (VTRS) Expected to Beat Earnings Estimates: Should You Buy?

Zacks

12 days ago

Viatris (VTRS) Expected to Beat Earnings Estimates: Should You Buy?

Cencora (COR) Earnings Expected to Grow: Should You Buy?

Zacks

13 days ago

Cencora (COR) Earnings Expected to Grow: Should You Buy?

Why Cencora (COR) is a Top Growth Stock for the Long-Term

Zacks

13 days ago

Why Cencora (COR) is a Top Growth Stock for the Long-Term

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Zacks

14 days ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Baxter Q3 Preview: Can Core Segments Deliver Another Solid Quarter?

Zacks

14 days ago

Baxter Q3 Preview: Can Core Segments Deliver Another Solid Quarter?

United State Cell and Gene Therapy Third-Party Logistics Market Analysis Report 2025-2033: Expansion Fueled by Rising R&D Expenditure, Regulatory Complexity, & Strong Demand from Major Biopharma Hubs

GlobeNewswire

14 days ago

United State Cell and Gene Therapy Third-Party Logistics Market Analysis Report 2025-2033: Expansion Fueled by Rising R&D Expenditure, Regulatory Complexity, & Strong Demand from Major Biopharma Hubs

MT Newswires

15 days ago

UBS Adjusts Cencora Price Target to $380 From $350, Maintains Buy Rating

World-Renowned Surgeon and Entrepreneur Dr. Mandeep S. Dhalla Invests in DentScribe.ai and Joins as Strategic Advisor

PR Newswire

15 days ago

World-Renowned Surgeon and Entrepreneur Dr. Mandeep S. Dhalla Invests in DentScribe.ai and Joins as Strategic Advisor

A Fresh Look at Cencora (COR) Valuation as Shares Rally 8% in the Past Month

Simply Wall St.

16 days ago

A Fresh Look at Cencora (COR) Valuation as Shares Rally 8% in the Past Month

Pharma, Specialty Units Likely to Drive Cardinal Health's Q1 Earnings

Zacks

18 days ago

Pharma, Specialty Units Likely to Drive Cardinal Health's Q1 Earnings

Universal Health to Report Q3 Earnings: Key Estimates to Note

Zacks

20 days ago

Universal Health to Report Q3 Earnings: Key Estimates to Note

What to Expect From Cencora's Q4 2025 Earnings Report

Barchart

20 days ago

What to Expect From Cencora's Q4 2025 Earnings Report

MT Newswires

21 days ago

Cencora Insider Sold Shares Worth $1,665,700, According to a Recent SEC Filing

Will Cencora (COR) Beat Estimates Again in Its Next Earnings Report?

Zacks

21 days ago

Will Cencora (COR) Beat Estimates Again in Its Next Earnings Report?

How McKesson’s (MCK) Exclusive PHYRAGO Distribution Could Shape Its Specialty Pharma Growth Trajectory

Simply Wall St.

23 days ago

How McKesson’s (MCK) Exclusive PHYRAGO Distribution Could Shape Its Specialty Pharma Growth Trajectory

Business Wire

a month ago

IntrinsiQ Specialty Solutions Expands Data Capabilities to Empower Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes

Cycle Pharmaceuticals Launches Its First Oncology Product, PHYRAGO™ (dasatinib) Tablets, in the US

Business Wire

a month ago

Cycle Pharmaceuticals Launches Its First Oncology Product, PHYRAGO™ (dasatinib) Tablets, in the US

MT Newswires

a month ago

Mizuho Adjusts Price Target on Cencora to $334 From $316, Maintains Outperform Rating

The Market Took a Hit. These 6 Stocks Can Sidestep the Wreckage.

Barrons.com

a month ago

The Market Took a Hit. These 6 Stocks Can Sidestep the Wreckage.

3 Market-Beating Stocks Worth Your Attention

StockStory

a month ago

3 Market-Beating Stocks Worth Your Attention

3 Reasons COR Has Explosive Upside Potential

StockStory

a month ago

3 Reasons COR Has Explosive Upside Potential

Does Cencora’s Strong 42% Rally Signal More Growth Ahead in 2025?

Simply Wall St.

a month ago

Does Cencora’s Strong 42% Rally Signal More Growth Ahead in 2025?

Here's Why Cencora (COR) is a Strong Growth Stock

Zacks

a month ago

Here's Why Cencora (COR) is a Strong Growth Stock

Bitcoin Miner Leads Two Health Care Stocks To New Highs

Investor's Business Daily

a month ago

Bitcoin Miner Leads Two Health Care Stocks To New Highs

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Zacks

a month ago

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

McKesson Bets on Oncology, Biopharma as It Streamlines Portfolio

Zacks

a month ago

McKesson Bets on Oncology, Biopharma as It Streamlines Portfolio

Business Wire

a month ago

Cencora Announces Date and Time for Fourth Quarter Fiscal 2025 Earnings Release

MT Newswires

a month ago

Leerink Partners Adjusts Cencora Price Target to $361 From $349, Maintains Outperform Rating

Morningstar Research

a month ago

Analyst Report: Cencora, Inc.

Morningstar Research

a month ago

Analyst Report: McKesson Corporation

Cardinal Health Stock Scores Relative Strength Rating Upgrade

Investor's Business Daily

a month ago

Cardinal Health Stock Scores Relative Strength Rating Upgrade

2 Large-Cap Stocks with Exciting Potential and 1 We Find Risky

StockStory

a month ago

2 Large-Cap Stocks with Exciting Potential and 1 We Find Risky

Is Cencora (COR) Undervalued? Exploring the Quiet Rally and What It Means for Investors

Simply Wall St.

a month ago

Is Cencora (COR) Undervalued? Exploring the Quiet Rally and What It Means for Investors

Why Cencora (COR) is a Top Growth Stock for the Long-Term

Zacks

2 months ago

Why Cencora (COR) is a Top Growth Stock for the Long-Term

1 Surging Stock with Exciting Potential and 2 We Find Risky

StockStory

2 months ago

1 Surging Stock with Exciting Potential and 2 We Find Risky

Morningstar Research

2 months ago

Analyst Report: McKesson Corporation

Business Wire

2 months ago

Kroll Settlement Administration Announces that The Lash Group, LLC Has Reached a Settlement Regarding a Data Security Incident

Top Analyst Reports for Apple, Eli Lilly & Chevron

Zacks

2 months ago

Top Analyst Reports for Apple, Eli Lilly & Chevron

Why Cencora (COR) Stock Is Trading Up Today

StockStory

2 months ago

Why Cencora (COR) Stock Is Trading Up Today

nuVizz to Showcase B2B Last-Mile Delivery Strategies at CSCMP EDGE 2025

GlobeNewswire

2 months ago

nuVizz to Showcase B2B Last-Mile Delivery Strategies at CSCMP EDGE 2025

MT Newswires

2 months ago

Cencora Insider Sold Shares Worth $1,478,130, According to a Recent SEC Filing

Cencora (COR) is a Top-Ranked Value Stock: Should You Buy?

Zacks

2 months ago

Cencora (COR) is a Top-Ranked Value Stock: Should You Buy?

MT Newswires

2 months ago

Cencora Insider Sold Shares Worth $9,087,142, According to a Recent SEC Filing

MT Newswires

2 months ago

Deutsche Bank Adjusts Price Target on Cencora to $322 From $328

MT Newswires

2 months ago

Deutsche Bank Trims Price Target on Cencora to $322 From $328, Keeps Buy Rating

Cencora Stock: Is COR Outperforming the Health Care Sector?

Barchart

2 months ago

Cencora Stock: Is COR Outperforming the Health Care Sector?

PACS Group, Inc. (PACS) Soars 24.5%: Is Further Upside Left in the Stock?

Zacks

2 months ago

PACS Group, Inc. (PACS) Soars 24.5%: Is Further Upside Left in the Stock?

MT Newswires

2 months ago

Argus Adjusts Price Target on Cencora to $340 From $330

Argus Research

2 months ago

Analyst Report: Cencora Inc

Argus Research

2 months ago

Market Digest: AAPL, COR, CCL, DECK, ETD, ETN, ORCL

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Zacks

2 months ago

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Here's Why You Should Hold Cencora Stock in Your Portfolio Now

Zacks

2 months ago

Here's Why You Should Hold Cencora Stock in Your Portfolio Now

Here's Why Cencora (COR) is a Strong Value Stock

Zacks

2 months ago

Here's Why Cencora (COR) is a Strong Value Stock

Cencora (COR) Appoints D. Mark Durcan As New Chairman Of The Board

Simply Wall St.

2 months ago

Cencora (COR) Appoints D. Mark Durcan As New Chairman Of The Board

COR vs. MEDP: Which Stock Is the Better Value Option?

Zacks

2 months ago

COR vs. MEDP: Which Stock Is the Better Value Option?

Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns

Zacks

2 months ago

Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns

MT Newswires

2 months ago

Cencora Appoints Mark Durcan as Chairman

Business Wire

2 months ago

Cencora Appoints Mark Durcan as Chairman of Its Board of Directors

Cencora (COR) is an Incredible Growth Stock: 3 Reasons Why

Zacks

2 months ago

Cencora (COR) is an Incredible Growth Stock: 3 Reasons Why

Morningstar Research

3 months ago

Analyst Report: McKesson Corporation

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Zacks

3 months ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

MT Newswires

3 months ago

Cencora Insider Sold Shares Worth $4,227,618, According to a Recent SEC Filing

Is Climb Bio, Inc. (CLYM) Outperforming Other Medical Stocks This Year?

Zacks

3 months ago

Is Climb Bio, Inc. (CLYM) Outperforming Other Medical Stocks This Year?

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Zacks

3 months ago

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Argus Research

3 months ago

Weekly Stock List

Cencora directors agree to $111M settlement over alleged opioid mismanagement

Healthcare Dive

3 months ago

Cencora directors agree to $111M settlement over alleged opioid mismanagement

Why Cencora (COR) is a Top Value Stock for the Long-Term

Zacks

3 months ago

Why Cencora (COR) is a Top Value Stock for the Long-Term

Cencora's (NYSE:COR) Earnings Seem To Be Promising

Simply Wall St.

3 months ago

Cencora's (NYSE:COR) Earnings Seem To Be Promising

Health Insurance Providers Stocks Q2 Teardown: Cencora (NYSE:COR) Vs The Rest

StockStory

3 months ago

Health Insurance Providers Stocks Q2 Teardown: Cencora (NYSE:COR) Vs The Rest

Cencora Stock: Analyst Estimates & Ratings

Barchart

3 months ago

Cencora Stock: Analyst Estimates & Ratings

MT Newswires

3 months ago

Wells Fargo Adjusts Price Target on Cencora to $354 From $337, Maintains Overweight Rating

The 5 Most Interesting Analyst Questions From Cencora’s Q2 Earnings Call

StockStory

3 months ago

The 5 Most Interesting Analyst Questions From Cencora’s Q2 Earnings Call

Morningstar Research

3 months ago

Analyst Report: Cardinal Health, Inc.

COR Q2 Deep Dive: Specialty Growth, International Headwinds, and Guidance Update

StockStory

3 months ago

COR Q2 Deep Dive: Specialty Growth, International Headwinds, and Guidance Update

3 Reasons Growth Investors Will Love Cencora (COR)

Zacks

3 months ago

3 Reasons Growth Investors Will Love Cencora (COR)

MT Newswires

3 months ago

JPMorgan Adjusts Price Target on Cencora to $344 From $326, Maintains Overweight Rating

Share on Social Networks: